| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451654A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | CA2451637A1 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | CA2451611A1 Total protein detection methods and devices at low ph |
| 01/03/2003 | CA2451437A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | CA2451367A1 Gas chromatograph with flame ionisation detector for parallel hydrocarbon analysis |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451250A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | CA2451222A1 Configurable dynamic three dimensional array |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2451161A1 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | CA2447843A1 Method for estimation of the amount of specific cell types |
| 01/03/2003 | CA2446218A1 Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| 01/03/2003 | CA2442710A1 Human secreted proteins |
| 01/03/2003 | CA2414786A1 Method for identifying substances which are suitable to be used for treating virus infections |
| 01/03/2003 | CA2387466A1 Acridinium ester labels having hydrophilic modifiers |
| 01/02/2003 | US20030005470 Animal model for use in the diagnosis and treatment of tumors and bone matastasis |
| 01/02/2003 | US20030004939 Search scheduling apparatus, program and recording medium having the same program recorded therein |
| 01/02/2003 | US20030004905 System and method for deconvoluting the effect of topography on scanning probe microscopy measurements |
| 01/02/2003 | US20030004710 Short-term enhancement in celp speech coding |
| 01/02/2003 | US20030004652 Systems and methods for monitoring behavior informatics |
| 01/02/2003 | US20030004650 Apparatus and method for determining biological heat potential |
| 01/02/2003 | US20030004474 Sample collection system |
| 01/02/2003 | US20030004431 Method and apparatus for measuring properties of a target surface |
| 01/02/2003 | US20030004426 Method and apparatus for detecting environmental smoke exposure |
| 01/02/2003 | US20030004402 Process for discriminating between biological states based on hidden patterns from biological data |
| 01/02/2003 | US20030004323 Novel antigen constructs useful in the detection and differention of antibodies to hiv |
| 01/02/2003 | US20030004320 Activated peptides and conjugates |
| 01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
| 01/02/2003 | US20030004315 Collagen |
| 01/02/2003 | US20030004311 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004307 Diagnosis indicator |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004113 Autoimmune disease; rheumatic disorders |
| 01/02/2003 | US20030004111 Bax fragment induced tumor cell death |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004095 Treatment of diabetes with milk protein hydrolysate |
| 01/02/2003 | US20030004093 Method for identifying compounds for inhibition of neoplastic lesions |
| 01/02/2003 | US20030003609 Ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 01/02/2003 | US20030003602 Homogeneous immunoassay method |
| 01/02/2003 | US20030003601 Biochemical analysis system and biochemical analysis unit |
| 01/02/2003 | US20030003600 Kit for use in the detection and accurate analysis of radioactivity in sample |
| 01/02/2003 | US20030003599 Arrays of protein-capture agents and methods of use thereof |
| 01/02/2003 | US20030003598 Method, system and computer program product for measuring unit activity of an enzyme |
| 01/02/2003 | US20030003597 Diagnosing pregnancy in humans; obtain sample, incubate with antibody, monitor complex formation, presence of complex indicates pregnancy |
| 01/02/2003 | US20030003596 Apparatus for use in solid phase extraction and organic analysis of environmental samples |
| 01/02/2003 | US20030003592 Detection of analytes in aqueous environments |
| 01/02/2003 | US20030003588 Method for kidney disease detection by protein profiling |
| 01/02/2003 | US20030003587 Fiber optic sensor for use in the detection of narcotics in blood sample |
| 01/02/2003 | US20030003580 Human cancer cell line malignantly altered by expression of angiogenic factor |
| 01/02/2003 | US20030003579 Dendritic cells; methods |
| 01/02/2003 | US20030003577 Generation of preferential monolayers of cell; obtain cell, culture, to monolayer, cool, incubate with water, embed cells sapphire covering, recover solid support with cell embedded |
| 01/02/2003 | US20030003571 Well unit for detecting cell chemotaxis and separating chemotactic cells |
| 01/02/2003 | US20030003570 Microsample treatment apparatus |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
| 01/02/2003 | US20030003524 Analytical element and measuring device and substrate quantification method using the same |
| 01/02/2003 | US20030003523 Conductometric detection process |
| 01/02/2003 | US20030003522 Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| 01/02/2003 | US20030003521 Marker for inflammatory conditions |
| 01/02/2003 | US20030003520 FXR receptor-mediated modulation of cholesterol metabolism |
| 01/02/2003 | US20030003518 Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases |
| 01/02/2003 | US20030003517 Methods of detecting dissociated nuclear hormone receptor ligands |
| 01/02/2003 | US20030003516 Therapeutic and diagnostic uses of antibody specificity profiles |
| 01/02/2003 | US20030003515 Diagnosing cardiovascular disorders; obtain sample, determine fibrinogen concentrations, compare to control, amplified concentration of fibrinogin indicates cardiovascular disorders |
| 01/02/2003 | US20030003514 Detecting and monitoring binding activity of antibody; obtain ligand, incubate with solid support, expose to sample containing antibody, detect signal from immune complex |
| 01/02/2003 | US20030003513 Compounds and methods for the inhibition of protein-protein interactions |
| 01/02/2003 | US20030003512 Qualitative and quantative analysis of preferential proteins in sample; obtain sample, expose to radiation, monitor absorption spectra |
| 01/02/2003 | US20030003510 Biophotonic sensors and methods of use thereof |
| 01/02/2003 | US20030003509 Detection of micoroganismal asthma attack; obtain tissue sample, monitor expression and decomposition of preferential cadherin |
| 01/02/2003 | US20030003508 Serological diagnostic method with rickettsia pulicis bacterium |
| 01/02/2003 | US20030003507 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2003 | US20030003506 Probe for analyzing protein-protein interaction and method of analyzing protein-protein interactions with the use of the same |
| 01/02/2003 | US20030003504 Flow cell for chemical reactions |
| 01/02/2003 | US20030003503 Enhancing sensitivity and equimolar detection through modifications of the reaction environment |
| 01/02/2003 | US20030003502 Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof |
| 01/02/2003 | US20030003501 Detection of preferential apolipoprotein in saliva; obtain saliva sample, incubate with antibodies, detect signal from bound complexes |
| 01/02/2003 | US20030003497 Detection of immunogenic polypeptide in sample; obtain animal, immunize, recover antibodies, incubate with samples, monitor adjustments in reactivity |
| 01/02/2003 | US20030003496 Novel compositions and methods for array-based nucleic acid hybridization |
| 01/02/2003 | US20030003494 Method for outputting results of comparison of abundances of biopolymers |
| 01/02/2003 | US20030003492 Colorimetric nanocrystal sensors, methods of making, and use thereof |
| 01/02/2003 | US20030003491 Method for detecting or quantifying environmental hormones |
| 01/02/2003 | US20030003490 Mapping preferential nucleic acid position in biopolymer; obtain nucleotide sequence sample, incubate with probe, amplify, determine position of preferential nucleotide sequences |